NYSEMKT: OCX
Oncocyte Corp Stock Ownership

Insider buying vs selling

Have Oncocyte Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Partners Lp Broadwood10% Owner2021-09-23573,461$3.15
$1.81MBuy
Andrew J. LastDirector2021-06-116,993$3.00
$20.98kBuy
Ronald Asbury AndrewsChief Executive Officer2021-03-1911,000$4.79
$52.70kBuy
Partners Lp Broadwood10% Owner2021-02-05600,000$4.50
$2.70MBuy

1 of 1

OCX insiders have bought more... subscribe to Premium to read more.
Ownership

OCX Shareholders

What type of owners hold Oncocyte Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Partners Lp Broadwood34.77%32,069,294$54.04MInsider
Broadwood Capital Inc18.81%17,349,945$29.23MInstitution
Pura Vida Investments LLC13.25%12,223,953$20.60MInstitution
Vida Investments Llc Pura13.25%12,223,953$20.60MInsider
Cell Therapeutics Inc Lineage6.55%6,041,154$10.18MInsider
Blackrock Inc4.74%4,368,736$7.36MInstitution
Vanguard Group Inc4.20%3,875,977$6.53MInstitution
George Karfunkel3.97%3,659,860$6.17MInsider
Orbimed Advisors LLC3.10%2,856,000$4.81MInstitution
Defender Capital LLC2.13%1,960,820$3.30MInstitution

1 of 3

Oncocyte Corp Stock Ownership FAQ

Who owns Oncocyte Corp?

Oncocyte Corp (NYSEMKT: OCX) is owned by 61.31% institutional shareholders, 60.09% Oncocyte Corp insiders, and 0.00% retail investors. Partners Lp Broadwood is the largest individual Oncocyte Corp shareholder, owning 32.07M shares representing 34.77% of the company. Partners Lp Broadwood's Oncocyte Corp shares are currently valued at $57.72M.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.